| Generic Name | Adalimumab (40mg/0.8ml) |
| Manufacturer | Alkem Laboratories Ltd |
| Packaging | vial of 1 Injection |
| Therapeutic Class | ANTI NEOPLASTICS |
| Action Class | Disease Modifying Anti-Rheumatoid Drugs (DMARDs)- Biologics |
| Habit Forming | ✓ No |
| Prescription Required | ✓ Yes (Schedule H Drug) |
Mabvinra 40mg Injection is a medicine used to treat a variety of conditions such as ankylosing spondylitis, rheumatoid arthritis, psoriasis, ulcerative colitis, and Crohn’s disease. It provides relief from swelling, pain, and redness associated with various disorders and improves physical function.Mabvinra 40mg Injection is given by a healthcare professional and should not be self-administered. You should use it regularly and at the same time each day to get the maximum benefit from it. Continue using it as recommended by your doctor and complete the dose even if you feel better.Some of the common side effects of this medicine include headache, sinus inflammation, rash upper respiratory tract infection, and injection site reactions such as pain, redness, and swelling. Talk to your doctor if any of these side effects do not go away with time or get worse. Your doctor may help with ways to reduce or prevent these symptoms.To make sure the medicine is safe for you, before taking it, let your doctor know if you have any problems with your heart, kidneys, or liver. You should also tell your doctor about all the other medicines you are taking. It is important for pregnant and breastfeeding women to ask the advice of their doctors before taking this medicine.
Administered by healthcare professional only.
Common and serious side effects may include:
Note: This is not a complete list. Consult your doctor if you experience any unusual symptoms.
Medicines with the same active ingredient Adalimumab (40mg/0.8ml) that may be more affordable:
Other medicines in the same therapeutic category: